Abstract Amyloidosis is a rare cause of myopathy. Its prominent or presenting feature may be respiratory failure. Physiological measurement of transdiaphragmatic pressure and biopsy specimens of muscle show the pathological mechanism to be diaphragm weakness due to amyloid infiltration of the diaphragm rather than parenchymal lung involvement. Thus amyloid myopathy even without the typical macroglossia and muscle pseudohypertrophy should be considered as one of the neurological causes of respiratory failure.
myasthenia gravis, acid maltase deficiency,3 and (rarely) porphyria.4 Amyloid myopathy, first described by Lubarsch in 1929,5 is a rare condition in which amyloid is deposited in the muscle. It is usually characterised by muscle weakness, pseudohypertrophy, and macroglossia,67 but is not yet commonly recognised as a cause of respiratory failure. Although two incompletely described cases have been reported,89 in neither case was the extent of diaphragm weakness documented. We describe a patient with amyloid myopathy presenting with respiratory failure who had physiologically documented weakness of the diaphragm.
Case report A 73 year old woman was admitted with a six month history of breathing difficulty followed by progressive weakness, weight loss, and malaise. She had dyspnoea at rest, most noticeable when supine. Weakness of arms and legs was gradual in onset and eventually impaired housework, getting out of a bath, and rising from a chair. She had no bulbar symptoms until just before admission, when her voice became weak and swallowing impaired. She had a history of non-insulin dependent diabetes mellitus and hypertension. Seventeen years before admission, she had had carcinoma of the breast treated by mastectomy and local irradiation. There was no family history of neurosmuscular or other neurological diseases. Medications on admission consisted of ranitidine, metoclopramide, cefotaxime, propoxyphene/acetaminophen, and prochlorperazine.
On examination she was anxious and alert.
Her respiratory rate was 32/min, heart rate 100/min, temperature 37°C, blood pressure 120/70, and the vital lung capacity was 700 ml. The apex beat was not displaced, and S4 was audible. She had an apical systolic murmur (2/6 Necropsy examination At necropsy amyloid was found in the diaphragm (figure 2), intercostal and psoas muscles, tongue, heart, and in the muscular Figure 2 Transverse section ofparaffin-embedded diaphragm, necropsy specimen, stained with Congo red. Green birefringence from amyloid deposition surrounds every muscle fibre. Shrinkage offibres away from encircling amyloidfibrils is artifact of preparation (magnification x 100).
layers of the ileum and jejunum. The diaphragm itself was not considerably thickened and, in fact, no pseudohypertrophy was noted except in the heart. No amyloid was deposited in the endoneurium or perineurium of the lumbo-sacral plexus or intramuscular nerves, nor was the vasa nervorum affected. Though there was a mild degree of amyloid deposition perivascularly in the lungs, there was no amyloid in lung parenchyma or the tracheobronchial tree, so that the only part of the respiratory system affected was the respiratory muscles.
Discussion
This patient had a myopathy as suggested clinically by proximal muscle weakness and documented electrophysiologically in many muscle groups. The most impressive feature of this myopathy is that it presented with prominent respiratory failure. The muscle biopsy and necropsy material, which stained strongly positive with Congo red and was birefringent to polarised light, confirmed the diagnosis of amyloid myopathy. 
